What are United Therapeutics's profit margins?

United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.

Where do United Therapeutics's ratios come from?

Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

United Therapeutics UTHR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	352.1%-2.4pp	354.5%-1.3pp	355.8%-0.3pp	356.2%+0.1pp	356%+0.1pp
Operating margin	187%-1.6pp	188.6%-1.0pp	189.5%+1.3pp	188.2%-1.2pp	189.4%-3.4pp
Net margin	163.6%+0.2pp	163.4%+0.4pp	163%+0.3pp	162.6%-0.5pp	163.1%-1.6pp
EBITDA margin	197.7%-1.4pp	199.1%-0.8pp	199.8%+1.5pp	198.3%-1.0pp	199.3%-3.0pp
Free cash flow margin	135.4%-5.6pp	141.1%-4.9pp	145.9%+3.3pp	142.6%+1.2pp	141.4%+7.6pp
Returns
Return on equity	79.3%+0.3pp	79%+0.5pp	78.5%+1.2pp	77.3%0.0pp	77.2%-0.1pp
Return on assets	69.9%+0.8pp	69.1%+1.1pp	68%+1.9pp	66.1%+1.0pp	65.1%+0.6pp
Efficiency
Asset turnover	1.7×0.0×	1.7×0.0×	1.7×0.0×	1.6×0.0×	1.6×0.0×
Inventory turnover	9.2×+0.2×	9×0.0×	9×-0.2×	9.2×-0.2×	9.5×-0.2×
Liquidity
Current ratio	25.1×-0.7×	25.7×+1.4×	24.4×+1.8×	22.5×+2.9×	19.6×+1.7×
Quick ratio	23.8×-0.7×	24.5×+1.2×	23.3×+1.7×	21.6×+2.8×	18.9×+1.6×
Cash ratio	10.4×-0.5×	10.9×+0.5×	10.4×+0.7×	9.7×+1.4×	8.3×+1.2×
Leverage
Interest coverage	271.6×+48.2×	223.4×+44.4×	179×+35.9×	143.1×+23.4×	119.7×+17.9×
Per Share
Book value per share	$561.02-2.6%	$576.06+2.7%	$560.78+2.4%	$547.51+5.5%	$518.92+6.7%
Valuation
Market capitalization	$79.01B+18.2%	$66.86B+8.5%	$61.63B+5.2%	$58.59B-3.1%	$60.48B+5.3%
Price / earnings	61.3×+8.8×	52.6×+2.5×	50.1×+0.6×	49.5×-3.5×	52.9×+1.2×
Price / sales	25.1×+3.6×	21.5×+1.1×	20.4×+0.3×	20.1×-1.5×	21.6×+0.3×
Price / book	12.1×+2.4×	9.7×+0.5×	9.2×+0.3×	8.9×-0.8×	9.7×0.0×
Free cash flow yield	23%-4.2pp	27.2%-1.9pp	29.1%+0.3pp	28.8%+2.3pp	26.5%+1.2pp
Earnings yield	27.5%-3.8pp	31.3%-1.2pp	32.5%-0.3pp	32.8%+2.4pp	30.5%-1.0pp
PEG ratio	6.2×+2.4×	3.8×+0.7×	3×+0.4×	2.6×0.0×	2.6×+0.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about United Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are United Therapeutics's profit margins?: United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.
Where do United Therapeutics's ratios come from?: Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.